Ttnp stock investing
60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. TTNP Stock Price and Chart — NASDAQ:TTNP — TradingView Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in development of therapeutics for the treatment of medical disorders. Its products include Probuphine, Ropinirole Implant, and T3 Implant. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA. TTNP | Stock Snapshot - Fidelity
TTNP Stock Forecast - Buy or Sell? Titan Pharmaceuticals
Titan Pharma Inc (OBB:TTNP) is a biomedical pharmaceutical company most known for its flagship drug, Probuphine, used to treat opioid addiction. Probuphine has proved to be effective in two why Titan Pharmaceuticals Inc. [TTNP] is a Good Choice for ... The Average True Range (ATR) for Titan Pharmaceuticals Inc. is set at 0.05, with the Price to Sales ratio for TTNP stock in the period of the last 12 months amounting to 5.88. TTNP Stock Performance Analysis: Titan Pharmaceuticals Inc. [TTNP] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -31.23. TTNP - Titan Pharmaceuticals Inc Stock quote - CNNMoney.com
Our flagship email guides investors to the most important, insightful items required to chart the trading day ahead. Critical Information Ahead of the U.S. Trading
Stock quote and company snapshot for TITAN PHARMACEUTICALS INC (TTNP), including profile, stock chart, recent news and events, analyst opinions, and 4 Mar 2020 The Stock Trading Reality Podcast - https://claytrader.com/podcast/ ClayTrader. com and its employees are not a Registered Investment Advisor 2 Mar 2020 This is because investors see reverse splits as potential signs of danger ahead. However, without the split, TTNP will be delisted from the 5 days ago Trading Rating : - 01/07, TITAN PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities
Investing Education and Resources. Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading
Detailed technical analysis and trading signals for the Titan Pharmaceuticals Inc Stock. TTNP Technical Analysis. A brief summary - strong Buy, Buy, strong Pattern, Timeframe, Reliability, Candles Ago, Candle Time. Emerging Patterns. Engulfing Bearish, 1M, Current. Bullish Engulfing, 30, Current. Doji Star Bearish Titan Pharmaceuticals gained 3.75% in the last trading day ( Monday, 6th Apr 2020 ), rising from $0.22 to $0.23 During the day the stock fluctuated 9.81% from a Real-time trade and investing ideas on Titan Pharmaceuticals Inc. TTNP from the largest community of traders and investors. TTNP Stock Summary. Titan Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 4.67% of US Investing Education and Resources. Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading Our flagship email guides investors to the most important, insightful items required to chart the trading day ahead. Critical Information Ahead of the U.S. Trading
View the real-time TTNP price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Titan Pharmaceuticals against related stocks people have also bought like ONTX, INPX, OCGN, and BIOC. 37,126 people own Titan Pharmaceuticals on Robinhood on April 4, 2020.
This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the 24 Mar 2020 [NASDAQ: TTNP] dipped by -4.19% on the last trading session, reaching $0.22 price per share at the time. Titan Pharmaceuticals Inc. represents TITAN PHARMA INC (TTNP) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on 27 Mar 2020 The present dividend yield for TTNP owners is set at 0, marking the return investors will get regardless of the company's performance in the 23 Mar 2020 On 20-03-2020 (Friday), TTNP stock construct a change of 2.64 in a total of its share price and finished its trading at 0.21. Profitability Ratios (NASDAQ:TTNP) has 33 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are
TTNP Stock Forecast - Buy or Sell? Titan Pharmaceuticals TTNP Stock Evaluation. Titan Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Important: Please note that 87% of user opinions on StockTwits are positive to the stock